Immune checkpoint inhibitors side effects and management.

Area of Science:

• Oncology
• Immunotherapy
• Cancer Treatment

Background:

• The next decade will see significant expansion in cancer immunotherapies, particularly immune checkpoint inhibitors.
• Increasing use of diverse checkpoint inhibitors and combinations leads to more complex side effects.
• Managing these adverse events is becoming more challenging for clinicians.

Purpose of the Study:

• To review the major side effects of current immune checkpoint inhibitors.
• To summarize effective management strategies for these adverse events.
• To support physicians in daily practice and enhance patient safety and quality of life.

Main Methods:

• Literature review of recent studies on immune checkpoint inhibitors.
• Synthesis of data on common and severe adverse events.
• Compilation of evidence-based management guidelines.

Main Results:

• Identification of key side effect profiles for major immune checkpoint inhibitors.
• Detailed description of management approaches for various adverse events.
• Emphasis on early recognition and intervention for better outcomes.

Conclusions:

• Immune checkpoint inhibitors offer significant advancements in cancer therapy.
• Proactive management of side effects is crucial for patient safety and treatment success.
• This review provides a practical resource for clinicians managing immunotherapy-related toxicities.